News

Qilu National engineering laboratory for High Expression of Mammalian Cells, Reported by Popular Daily

ABOUT US

News

Qilu National engineering laboratory for High Expression of Mammalian Cells, Reported by Popular Daily

Release time：

2010-07-16

Qilu Pharmaceutical began the research for genetic medicines in 1997. Till now the company has invested nearly 3 hundred million CNY to build both research centers and production sites for biotechnology derived medicine especially the National engineering laboratory for High Expression of Mammalian Cells. Relying on the high standard laboratory, the company has established a large-scale culture platform for CHO cells which can achieve international level.

Besides the 2500 Square meters production site, Qilu has built a new production site for Genetic engineering drugs. The seven large-scale lines which are in accord with the European CGMP will surely accelerate the development of Qilu bio-industry in future.

Qilu Pharma was awarded “National Comprehensive R&D of New Drugs (Shandong) Demonstration Enterprise

Qilu Held the “QILU CUP” Staff Basketball Match

Related News

Qilu Launches First Generic Version of Invega Sustenna® (Paliperidone Palmitate Suspension for Injection) in China

2023-10-12

Qilu Pharmaceutical launched the first innovative drug in China

2023-09-01

Qilu Pharmaceutical Group Awarded as Socially Responsible Enterprises (Entrepreneurs) in 2022

2023-04-04

Qilu Pharmaceutical ranks No.5 in the list of "Top 100 Enterprises in Chinese Pharmaceutical Industry”

2022-12-19

Qilu Pharmaceutical ranked 5th among China's top 100 list